Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin vs Levofloxacin + Metronidazole in PID (MONALISA)
NCT00453349Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2007
- Primary completion
- May 2008
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
A Phase 3 trial of moxifloxacin in pelvic inflammatory disease (PID), sponsored by Bayer. Started Jan 2007; status: completed.
02
Drugs
moxifloxacin
03
Conditions
pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT00453349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453349.